Table 1.

Demographic, Clinical and Pathologic Characteristics by Treatment Group^*

	Primary Debulking Surgery (PDS) n (%)	Neoadjuvant Chemotherapy (NAC) n(%)
No. of patients	4,827	958
Age (years)
65–69	1066 (22.08)	188 (19.62)
70–74	1383 (28.65)	268 (27.97)
75–79	1282 (26.56)	270 (28.18)
80–84	731 (15.14)	171 (17.85)
85+	365 (7.56)	61 (6.37)
Race
White	4352 (90.16)	843 (88.00)
Black	230 (4.76)	60 (6.26)
Other	174 (3.60)	39 (4.07)
Median Household Income
First Quartile	1140 (23.62)	176 (18.37)
Second Quartile	1158 (23.99)	224 (23.38)
Third Quartile	1136 (23.53)	260 (27.14)
Fourth Quartile	1194 (24.74)	246 (25.68)
Marital Status
Married	2190 (45.37)	502 (52.40)
Not Married	2499 (51.77)	431 (44.99)
Region
Northeast	933 (19.33)	196 (20.46)
Midwest	1016 (21.05)	193 (20.15)
South	677 (14.03)	121 (12.63)
West	2201 (45.60)	448 (46.76)
Area of Residence
Large Metropolitan	2762 (57.22)	579 (60.44)
Metropolitan	1290 (26.72)	256 (26.72)
Urban	293 (6.07)	67 (6.99)
Less Urban	381 (7.89)	13 (1.36)
Rural	101 (2.09)	13 (1.36)
Stage
III	3401 (65.05)	482 (50.31)
IV	1599 (33.13)	454 (47.39)
Grade¥
Low	871 (18.04)	98 (10.22)
High	2983 (61.80)	426 (44.47)
Unknown	970 (20.10)	434 (45.30)
Histology
Serous/Adenocarcinoma	3674 (76.11)	797 (83.19)
Mucinous	197 (4.08)	25 (2.61)
Endometroid	304 (6.30)	21 (2.19)
Clear Cell	78 (1.62)	13 (1.36)
Other Epithelial	574 (11.89)	102 (10.65)
Comorbidity Score
0	3271 (67.76)	615 (64.20)
1	1023 (21.19)	217 (22.65)
2	326 (6.75)	76 (7.93)
3+	207 (4.29)	50 (5.22)

^*Not all totals add up to 100% because of rounding and missing data,

^¥low grade= grade 1 or 2 according to the SEER data; high grade = grade 3 or 4 as listed in SEER